Skip to main content

Advertisement

Table 1 Physical and clinical characteristics of the study populations

From: IL-33 is negatively associated with the BMI and confers a protective lipid/metabolic profile in non-diabetic but not diabetic subjects

Characteristics LN OW OBS Total
(a)
Number of subjects 10 8 13 31
Age range (Years) 32.4 ± 9.2 36.75 ± 7.12 43.8 ± 12.8 38.7 ± 11.35
Total body weight 58.5 ± 11.9 80.2 ± 11.45 *85.4 77 ± 19.5
Body mass index *22.95 28.2 ± 1.67 33.4 ± 2.66 28.54 ± 5.3
HbA1c (%) 5.38 ± 0.32 5.47 ± 0.34 5.72 ± 0.32 5.55 ± 0.35
Fasting blood glucose (mmol/l) 4.8 ± 0.45 5.05 ± 0.38 5.15 ± 0.36 5.015 ± 0.41
Total cholesterol (mmol/l) 5.14 ± 1.3 5.2 ± 0.65 5.27 ± 1.1 5.2 ± 1.03
HDL-C (mmol/l) 1.35 ± 0.34 1.32 ± 0.34 1.15 ± 0.26 1.26 ± 0.315
LDL-C (mmol/l) 3.2 ± 0.97 3.4 ± 0.76 3.6 ± 1.0 3.43 ± 0.93
TGL (mmol/l) *0.715 1.1 ± 0.53 1.1 ± 0.41 1.02 ± 0.46
Characteristics DM LN DM OW DM OBS Total
(b)
Number of subjects 1 2 12 15
Age range (Years) 40 53 ± 14.14 50 ± 11.7 49.5 ± 11.4
Total body weight 88.5 81.4 ± 11.17 95.25 ± 12.1 92.96 ± 12.2
Body mass index 24.77 28.97 ± 0.66 34.35 ± 2.8 33 ± 3.9
HbA1c (%) 8.5 6.95 ± 0.49 8.88 ± 1.75 8.6 ± 1.7
Fasting blood glucose (mmol/l) 5.6 7.22 ± 1.3 10.40 ± 4.7 9.66 ± 4.5
Total cholesterol (mmol/l) 3.6 4.52 ± 0.54 5.01 ± 1.1 4.85 ± 1.1
HDL-C (mmol/l) 1.46 0.91 ± 0.09 *1.17 *1.13
LDL-C (mmol/l) 1.9 2.85 ± 0.64 2.85 ± 1.2 2.78 ± 1.1
TGL (mmol/l) 0.57 1.55 ± 0.05 1.81 ± 0.88 1.69 ± 0.85
  1. (a) Data represent non-diabetic subjects with an HbA1c < 6.5. (b) Data represent diabetic subjects with an HbA1c > 6.5. Data shown represent standard deviation of the mean (*data that were not normally distributed are shown as medians).